<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="3" ids="16335">Adenosine</z:chebi> is an endogenous neuromodulator with anticonvulsive and neuroprotective activity </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="3" ids="16335">Adenosine</z:chebi> levels are normally kept in the range of 20 to 200 nmol/L by low basal expression of its main metabolic enzyme, <z:chebi fb="3" ids="16335">adenosine</z:chebi> kinase (ADK) </plain></SENT>
<SENT sid="2" pm="."><plain>Dysfunction of the adenosinergic system has been demonstrated to contribute to epileptogenesis </plain></SENT>
<SENT sid="3" pm="."><plain>To investigate whether upregulation of ADK may render the brain more susceptible to ischemic cell <z:hpo ids='HP_0011420'>death</z:hpo>, mutant mice overexpressing an Adk transgene in brain were subjected to middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="4" pm="."><plain>One day after either 15 or 60 mins of MCAO, <z:mp ids='MP_0002169'>wild-type</z:mp> (WT) animals had <z:mpath ids='MPATH_124'>infarct</z:mpath> areas encompassing about 5% and 50% of their ischemic hemisphere, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>In marked contrast, the volume of the <z:mpath ids='MPATH_124'>infarcts</z:mpath> increased three-fold in Adk transgenic mutants after 15 mins of MCAO, and after 60 mins of MCAO <z:hpo ids='HP_0000001'>all</z:hpo> mutants died within 24 h </plain></SENT>
<SENT sid="6" pm="."><plain>Pretreatment of the mutants with the ADK inhibitor <z:chebi fb="0" ids="40167">5-iodotubercidin</z:chebi> led to lesions similar to those in WT mice </plain></SENT>
<SENT sid="7" pm="."><plain>Thus, low levels of ADK are essential to maintain <z:chebi fb="3" ids="16335">adenosine</z:chebi>-mediated neuroprotection </plain></SENT>
<SENT sid="8" pm="."><plain>We conclude that pathologic overexpression of ADK as in <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> may also render the brain more susceptible to injury from <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Consequently, ADK emerges as a rational therapeutic target to enhance neuroprotection </plain></SENT>
</text></document>